EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase

Jessica A Wright iD, Stephanie D White iD, Gavin Frame, Ana Bosiljkov, Shahbaz Khan, Roni Haas iD, Qian Yang, Minzhi Sheng iD, Xiaoyong Huang, Geoff S Higgins, Ian Mills iD, Michelle R Downes und 7 weitere

Cells · 2025

DOI: 10.3390/cells14110819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Jessica A Wright und 18 weiteren Autor:innen. Beteiligte Einrichtung: Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiation Tolerance, Nicotinamide N-Methyltransferase, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prostate Cancer Canada, CIHR, Canadian Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer cell lines are particularly clinically homogenous, mostly representing metastatic states rather than localized disease. While there has been significant work in the development of additional models, few have been created without oncogenic transformation. We derived a primary prostate cancer cell line from a patient with localized Gleason 7 prostate cancer—designated CaB34—which spontaneously immortalized. We leveraged CaB34 to generate a paired radioresistant subline, CaB34-CF, using a clinically relevant fractionated radiotherapy schedule. These two paired cell lines were investigated extensively to determine their molecular characteristics and therapy responses. Both CaB34 and CaB34-CF express prostate-specific markers, including KRT18, NKX3.1, and AMACR. Multi-omic analyses using RNAseq and shotgun proteomics identified NNMT as the most significantly dysregulated component in CaB34-CF. A bioinformatic analysis determined that NNMT was more abundant within prostate tumors compared to benign prostate, suggesting a role in tumor progression. Knockdown studies of NNMT demonstrated significant radiosensitization of CaB34-CF cells, which was largely a result of increased radiation-induced cellular senescence. Growth as 3D organoids was significantly higher in the CaB34-CF line, and demonstrated a less structured pattern of expression of cytokeratin markers. Radiosensitization with NNMT siRNA was recapitulated in a 3D organoid clonogenic assay in CaB34-CF cells. Our research provides a paired primary model of treatment-naïve and radioresistant disease to address mechanisms of therapy resistance, while expanding the repertoire of localized prostate cancer cell lines for the research community. In addition, our findings present NNMT as a potential therapeutic target for sensitization of radioresistant disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRadiation ToleranceNicotinamide N-MethyltransferaseModels, BiologicalHumansMaleCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

cell culturepreclinical modelsprostate cancerradiotherapy

Substanzen

Nicotinamide N-Methyltransferase

Autor:innen und Institutionen

  • Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2C4, Canada.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
  • Departments of Human Genetics and Urology, University of California, Los Angeles, CA 90095, USA.
  • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90024, USA.
  • Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.

ORCID-Profile: Jessica A Wright, Stephanie D White, Roni Haas, Minzhi Sheng, Ian Mills, Danny Vesprini, Hon S Leong, Paul C Boutros, Thomas Kislinger, Stanley K Liu

Förderung

  • Prostate Cancer Canada
  • CIHR
  • Canadian Cancer Society
  • Cancer Research UK
  • Prostate Cancer Canada Movember Discovery Grant
  • Canadian Institute of Health Research
  • Canadian Cancer Society Challenge Grant
  • Prostate Cancer Canada Movember Rising Star 728

Zitieren

APA

Wright, J. A., White, S. D., Frame, G., Bosiljkov, A., Khan, S., Haas, R., Yang, Q., Sheng, M., Huang, X., Higgins, G. S., Mills, I., Downes, M. R., Vesprini, D., Chung, H. T., Screaton, R. A., Leong, H. S., Boutros, P. C., Kislinger, T., & Liu, S. K. (2025). A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase. Cells. https://doi.org/10.3390/cells14110819

Vancouver

Wright JA, White SD, Frame G, Bosiljkov A, Khan S, Haas R, et al. A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase. Cells. 2025. doi:10.3390/cells14110819

BibTeX
@article{Wright2025,
  author = {Wright, Jessica A and White, Stephanie D and Frame, Gavin and Bosiljkov, Ana and Khan, Shahbaz and Haas, Roni and Yang, Qian and Sheng, Minzhi and Huang, Xiaoyong and Higgins, Geoff S and Mills, Ian and Downes, Michelle R and Vesprini, Danny and Chung, Hans T and Screaton, Robert A and Leong, Hon S and Boutros, Paul C and Kislinger, Thomas and Liu, Stanley K},
  title = {A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14110819}
}
Kostenlos starten →